To determine t h e proportion and subtype of a c u t e lymphoblastic leukemias which have n a t u r a l k i l l e r (NK) phenotype and a c t i v i t y , we examined leukemic b l a s t s from 31 c h i l d r e n with ALL (14 with T-ALL, 17 with non-T-ALL) f o r expression of antigens detected by NK-specific monoclonal a n t i b o d i e s Leu l l b , Leu 7, and 1G2 (an antibody we have developed which cross-reacts with Leu 7). None of t h e p a t i e n t s had leukemic b l a s t s which reacted w i t h Leu l l b . However, leukemic b l a s t s from 4 T-ALL p a t i e n t s were Leu 7+/1~2+. B l a s t s from 2 of t h e s e had spontaneous l y t i c a c t i v i t y a g a i n s t standard NK t a r g e t c e l l l i n e K562; b l a s t s from one k i l l e d K562 only when incubated w i t h i n t e r f e r o n ; b l a s t s from t h e o t h e r had no l y t i c a c t i v i t y a g a i n s t K562 but d i d manifest antibodydependent cell-mediated c y t o t o x i c i t y a g a i n s t antibody-coated c e l l s from NK-resistant c e l l l i n e SB. When leukemic b l a s t s from 6 Leu 7-/1G2-leukemic p a t i e n t s (2 with T-ALL, 3 with non-T-ALL, 1 with AML) were t e s t e d none had N K a c t i v i t y a g a i n s t K562. B l a s t s from a l l 4 Leu 7+/1~2+ p a t i e n t s had L2 morphology. I n one, t h e leukemic b l a s t s had a z u r o p h i l i c cytoplasmic granules s i m i l a r t o t h o s e found i n NK-enriched normal populations of l a r g e granular lymphocytes.
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These findings i n d i c a t e t h a t a s i g n i f i c a n t proportion of s u b j e c t s w i t h T-ALL have a malignancy of NK c e l l o r i g i n . Vitamin-K=dependent p r o t e i n C (PC) functions a s a p o t e n t a n t icoagulant. Thrombo-embolism has been reported i n kindreds with c o n g e n i t a l l y low PC l e v e l s suggesting t h a t PC has an important r o l e i n hemostasis and t h a t even a moderate reduction i n t h i s plasma p r o t e i n may b e a s s o c i a t e d with increased r i s k of thrombosis. Since thrombotic phenomena have important r o k s i n t h e vasoocclusive manifestations i n SCD, PC was determined i n 32 SCD during steady s t a t e and i n c o n t r o l s ( C ) . The SCD had s i g n i f i c a n t l y lower PC l e v e l s a s compared t o cont r o l s . S i x SCD were a l s o s t u d i e d during vaso-occlusive c r i s i s (VOC). During VOC t h e r e was marked decrease i n PC a s compared t o l e v e l s during steady s t a t e (49.5 5 6.4 and 66.1 5 10.0, respect i v e l y . P(0.01). Decreased l e v e l s of PC during VOC increased t o i n i t i a l l e v e l s o r higher with c l i n i c a l improvement. I t i s p o s t u l a t e d t h a t t h e decreased l e v e l s of PC i n SCD a r e probably secondary t o increased consumption a s well a s decreased production because of a l t e r e d l i v e r functions. This d a t a suggests t h a t decreased l e v e l s of PC may i n c r e a s e t h e r i s k of thrombosis i n t h e s e p a t i e n t s . Helper/suppressor (H-S) c e l l abnormalities a r e found i n more than 70% of hemophilia persons who a r e receiving f a c t o r VIII concentrates. I n t e r l e u k i n 2 (IL2) o r T c e l l growth f a c t o r i s a lymphokine produced by t h e helper c e l l a s well a s o t h e r c e l l s . We studied 12 hemophilia s u b j e c t s , 7 who received f a c t o r VIII concentrates and 5 who received c r y o p r e c i p i t a t e . All those r e c e i v i n g f a c t o r V I I I and 2 of t h e 5 receiving c r y o p r e c i p i t a t e had reversed H-S r a t i o s . IL2 was assayed on t h e supernates of PHA-stimulated mononuclear c e l l s previously i s o l a t e d on a f i c o l lhypaque d e n s i t y gradient. The t a r g e t c e l l was a human IL2 dependent T c e l l l i n e e s t a b l i s h e d by s t i m u l a t i n g normal mononuclear c e l l s with PHA f o r 3 days. The c e l l s were incubated f o r a f u r t h e r 4 days i n media containing 50%, 4x concentrated IL2 previously prepared from PHA stimulated supernates pooled from normals.
PLASMA PROTEIN C LEVELS I N PATIENTS WITH SICKLE CELL

DISEASE (SCD)
.
HIGH LEVELS OF INTERLEUKIN
INTERLEUKIN 2 LEVELS (UNITS) CONTROLS (16) CRYOPRECIPITATE (5) FACTOR VIII (7) M f S D 1 . 2 8 * 0 . 5 2.03 * 0.82 1.69 f 0.37 P -NS 0.008 S i g n i f i c a n t high l e v e l s of IL2 were found i n hemophilia persons r e c e i v i n g f a c t o r VIII concentrate and c r y o p r e c i p i t a t e . It i s p o s s i b l e t h a t a r e c e p t o r d e f e c t accounts f o r t h e H c e l l f a i l u r e .
THE INHIBITORY EFFECT OF TIN PROTOPORPHYRIN (SN-P)
922 ON HEME DEGRADATION. Stephen Landaw, Shigeru Sassa, George Drummond & A t t a l l a h Kappas. VA Medical Center Svracuse. NY & The Rockefeller U n i v e r s i t v HOSD.. NYC. NY.
-" Sn-P i s a ootent comoetitive i n h i b i t & o f heme oxiaenase, t h e enzyme which converts heme t o b i l e pigment and carbon-monoxide (CO), and has been used t o suppress hyperbilirubinemia i n experimental animals and man. These experiments were performed t o determine which heme pools a r e a f f e c t e d by Sn-P. Hepatic heme(s) were l a b e l e d w i t h del ta-aminolevul i n i c a c i d (ALA)-5-14~, which does n o t l a b e l hemoglobin heme i n t h e r a t . The " f r e e " heme pool was t e s t e d by i n j e c t i n g heme prepared i n v i v o from g l y c i n e -2 -1 4~ A d u l t (3009) r a t s were i n j e c t e d e i t h e r w i t h Sn-P (50uM/kg sq) or s a l i n e one hour before i n j e c t i o n w i t h e i t h e r lOuCi ALA-5-14~ o r 0.9mg hemin ( s p e c i f i c c t i v i t y 3x104 DPM/mg i n l m l a l k a l i n i z e d r a t plasma). Expired 18C0 was then c o l l e c t e d over t h e n e x t 24 hours. Results were: I n h i b i t i o n by Sn-P ( 
These experiments i n d i c a t e t h a t a s i n g l e i n j e c t i o n o f Sn-P s i gn i f i c a n t l y i n h i b i t s t h e degradation o f hepatic (non-erythropoiet i c ) hemes f o r 12 hours and exogenous heme f o r an even longer period. They f u r t h e r suggest t h a t Sn-P may e x e r t d i f f e r e n t degrees o f i n h i b i t i o n o f b i l i r u b i n (and CO) formation depending upon t h e heme pool ( s ) involved.
GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY, 
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A t h r e e year o l d white male with Class I glucose-6-phosphate dehydrogenase (G-6-PD) deficiency developed f e v e r and l e t h a r g y . I n s p i t e of a n t i b i o t i c s , he developed s e p t i c shock and died twelve hours l a t e r . Blood and post-mortem l i v e r c u l t u r e s grew Chromobacterium violaceum. Molecular present present present Chemiluminescence was profoundly abnormal i n t h e twin. G-6-PD i s o l a t e d from t h e t w i n ' s f i b r o b l a s t s demonstrated heat l a b i l i t y (27% of i n i t i a l a c t i v i t y ) , normal G-6-P K m (56uM) and pH curve, and increased u t i l i z a t i o n of 2-d-G6P (76% of G-6-P r a t e ) ; suggesting a new molecular v a r i a n t (G6-PD Beaumont).
This i s t h e f i r s t reported l e t h a l i n f e c t i o n i n a c h i l d with n e u t r o p h i l dysfunction due t o PMN G-6-PD deficiency. This en- Children with rhabdomyosarcoma who h a v e localized g r o s s residual disease a f t e r s u r g e r y (Group I11 disease) a r e a t h i g h r i s k f o r disease r e c u r r e n c e a n d death. I n t h e f i r s t national s t u d y (IRS-I, 1972-78) , 261 Gp 111 p t s were t r e a t e d with VACf adriamycin f o r 2 y r s p l u s postoperative radiation. At 3 y r s , t h e relapse-free s u r v i v a l (RFS) r a t e was 60% a n d t h e overall s u r v i v a l r a t e was 57%. I n IRS-I1 , 370 p t s were t r e a t e d with intensive repetitive pulse VAC* adriamycin f o r 2 y r s a n d postoperative radiation. P t s . with cranial parameningeal (PM) tumors a t r i s k of CNS extension received, i n addition, cranial radiation p l u s intrathecal methotrexate, hydrocortisone a n d cytosine arabinoside. T h e 3-yr RFS a n d overall s u rvival r a t e s of 72% a n d 70% o n IRS-I1 were s u p e r i o r ( P < .002) t o IRS-I r e s u l t s . T h e major reason f o r improved outcome was t h e s u p e r i o r r e s u l t s i n PM p t s who accounted f o r 37% of Gp I11 p t s i n b o t h studies. T h e 3-yr RFS a n d overall s u r v i v a l r a t e s f o r PM p a t i e n t s i n IRS-I1 vs.-I were: 72% v s . 58% (pz.04); 69% v s . 52% (p=.002). Improved outcome f o r all o t h e r p t s was l e s s significant (IRS-I1 vs.-I:
RFS-72% v s . 60%; overall s u r v i v a l -68% v s . 58%: pz.08 f o r b o t h ) . We conclude t h a t CNS prophylaxis improves s u r v i v a l i n p t s . with PM tumors a n d t h a t intensive chemotherapy f o r 2 y r s improves t h e outcome f o r all Gp I11 p t s .
